NIH Funding Opportunities

Subscribe to NIH Funding Opportunities feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 3 hours 58 min ago

Notice of Intent to Publish a Funding Opportunity Announcement for Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)

Wed, 03/06/2019 - 06:59
Notice NOT-AA-19-014 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)

Tue, 03/05/2019 - 23:16
Funding Opportunity RFA-NS-19-015 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose the comprehensive functional validation of newly identified therapeutic target candidates for Alzheimer's Disease-Related Dementias (ADRDs). This FOA seeks to promote critical target validation approaches to help de-risk subsequent translational research and accelerate the advancement of novel therapies for ADRD. Target(s) or molecular pathway(s) to be considered for validation must have been already identified using tissue expression or genetic data generated in human samples. In its initial phase, this FOA provided support for up to two years (UG3 stage) for the development of customized technologies, models, and protocols to modulate the expression or activity of target candidate(s) in cells or tissues and monitor their functional biological consequences in in vitro or in vivo disease models. Upon demonstration of technical feasibilities, a second phase (UH3 stage) will carefully and reproducibly measure and cross-validate the impact of the target modulation in different modalities across collaborating laboratories using the NIH rigor and reproducibility guidelines. Applicants responding to this FOA must address objectives for both the UG3 and UH3 phases and are expected to have a substantial collaborative effort between independents laboratories. This FOA is not specific for any one or group within the ADRD spectrum of disorders. Disorders covered in these applications are frontotemporal degeneration (FTD), Lewy body dementias (LBD) (including dementia with Lewy bodies (DLB)), Parkinson disease dementia (PDD), vascular contributions to cognitive impairment and dementia (VCID), mixed dementias including the associated diagnostic challenges of multiples etiology dementias (MED).
Categories: Science RSS Feeds

Notice of Special Interest: High-Priority Research Topics for PAR-19-071

Tue, 03/05/2019 - 09:22
Notice NOT-AG-19-007 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Notice of Special Interest: Administrative Supplements for Activities to Promote Human Immune-Representing Oncology Models

Tue, 03/05/2019 - 09:16
Notice NOT-CA-19-028 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

AHRQ Notice of Extension of PA-17-247

Tue, 03/05/2019 - 09:11
Notice NOT-HS-19-012 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)

Tue, 03/05/2019 - 06:57
Funding Opportunity PAS-19-210 from the NIH Guide for Grants and Contracts. This purpose of this FOA is to identify risk factors for dementia progression in PDD. Applicants must have access to well-characterized populations of PDD patients that have been followed longitudinally that they can continue to follow with clinical assessments and biospecimen collection until autopsy. Research should propose to identify clinical, pathological and/or biospecimen factors that predict which patients will develop cognitive impairment and/or dementia.
Categories: Science RSS Feeds

Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)

Tue, 03/05/2019 - 05:53
Funding Opportunity RFA-AI-19-028 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to establish a coordinated network of Emerging Infectious Disease Research Centers (EIDRCs) in regions around the globe where emerging and re-emerging infectious disease outbreaks are likely to occur. Multidisciplinary teams of investigators will conduct pathogen/host surveillance, study pathogen transmission, pathogenesis and immunologic responses in the host, and will develop reagents and diagnostic assays for improved detection for important emerging pathogens and their vectors.
Categories: Science RSS Feeds

Notice of NEI Participation in PAR-19-158 "Bioengineering Research Grants (R01 Clinical Trial Not Allowed)"

Tue, 03/05/2019 - 00:21
Notice NOT-EY-19-014 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Notice of NEI Participation in PAR-19-157 "Bioengineering Research Partnerships (U01 Clinical Trial Required)"

Tue, 03/05/2019 - 00:15
Notice NOT-EY-19-013 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Pages